Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
US6017539A · kind A · utility
4Cited by
7References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 1997 |
| Grant date | Jan 25, 2000 |
| Priority date | — |
| Expiry date | May 7, 2017 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/135
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Multimeric hybrid genes encoding the corresponding chimeric protein comprise a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen. The pathogens particularly are parainfluenza virus (PIV) and respiratory syncytial virus (RSV). A single recombinant immunogen is capable of protecting infants and similar susceptible individuals against diseases caused by both PIV and RSV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.